Literature DB >> 8995988

Cardiorespiratory response to exercise after venous switch operation for transposition of the great arteries.

H Douard1, L Labbé, J L Barat, J P Broustet, E Baudet, A Choussat.   

Abstract

STUDY
OBJECTIVES: This study reports on the cardiorespiratory response to graded exercise in patients after venous switch operation for transposition of the great arteries.
DESIGN: Several small studies have documented a diminished exercise tolerance after Mustard repair for transposition of the great arteries, little information exists, however, about long-term cardiorespiratory exercise performance in patients who have had the Senning procedure. PATIENTS: This prospective study reports on the serial long-term (mean, 11 +/- 2.8 years) cardiopulmonary exercise performance of 43 patients (age, 12 +/- 3.1 years) who underwent a Senning procedure, with no significant postoperative abnormalities. Forty-three matched healthy children were also studied as a control group. MEASUREMENTS AND
RESULTS: All underwent exercise testing (Bruce protocol) with metabolic gas exchange to determine parameters at 3 min, anaerobic threshold, similar heart rate (150 beats/min), and peak exercise. Time of exercise was 10.5 +/- 1.9 min in patients and 13.4 +/- 2 min in control subjects (p = 0.0001). Overall, patients reached 73% of peak oxygen uptake achieved by control subjects (32.6 +/- 5.6 vs 44.7 +/- 6 mL/kg/min). Chronotropic response (188 +/- 15.7 vs 166.5 +/- 19.6 beats/min [p = 0.0001]) and oxygen pulse (7.4 +/- 2.9 vs 10.7 +/- 4.2 mL/beat [p = 0.0002]) were lower in patients at peak exercise. Patients had a greater respiratory response to exercise: both respiratory rate and ventilatory equivalent for carbon dioxide were significantly higher at all stages of exercise. Exercise capacity assessed by peak oxygen uptake was correlated with time elapsed since surgical repair (r = 0.48; p = 0.001).
CONCLUSIONS: It is concluded that even in asymptomatic patients, exercise endurance and respiratory response are generally altered as much as 11 +/- 2.8 years after venous switch operation, although early surgical repair is predictive of a better long-term functional result.

Entities:  

Mesh:

Year:  1997        PMID: 8995988     DOI: 10.1378/chest.111.1.23

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Recovery kinetics of oxygen uptake is abnormally prolonged in patients with Mustard/Senning repair for transposition of the great arteries.

Authors:  A Giardini; S Specchia; G Coutsoumbas; A Donti; G Gargiulo; M Bonvicini; F M Picchio
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

Review 2.  Maximising the clinical use of exercise gaseous exchange testing in children with repaired cyanotic congenital heart defects: the development of an appropriate test strategy.

Authors:  A McManus; M Leung
Journal:  Sports Med       Date:  2000-04       Impact factor: 11.136

3.  Quality of life and psychosocial functioning of children with cardiac arrhythmias.

Authors:  Elizabeth R Pulgaron; Diana Wile; Kerri Schneider; Ming-Lon Young; Alan M Delamater
Journal:  Cardiol Young       Date:  2012-04-18       Impact factor: 1.093

4.  Oxygen uptake versus exercise intensity: a new concept in assessing cardiovascular exercise function in patients with congenital heart disease.

Authors:  T Reybrouck; L Mertens; S Brusselle; M Weymans; B Eyskens; J Defoor; M Gewillig
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

5.  Exercise Capacity in Children and Adolescents With Congenital Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Yenny Villaseca-Rojas; Javiera Varela-Melo; Rodrigo Torres-Castro; Luis Vasconcello-Castillo; Guillermo Mazzucco; Jordi Vilaró; Isabel Blanco
Journal:  Front Cardiovasc Med       Date:  2022-05-04

Review 6.  Factors influencing adaptation and performance at physical exercise in complex congenital heart diseases after surgical repair.

Authors:  P P Bassareo; L Saba; P Solla; C Barbanti; A R Marras; G Mercuro
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.